Saturday, December 10, 2016 11:57:06 AM
The fact is that NWBO recovered above their prior R/S price to get on the Nasdaq. If you had bought in like subatomic you would have been up. I don't know what year you bought in on this stock but I would guess that you bought shares above the prior R/S price. Is that true?
And yes, I truly believe that if NWBO was able to a R/S to stay on the Nasdaq that they would have recovered above their R/S price. You may have sold out, and tried to chase others to the bottom price. Meanwhile I pretty sure I wouldn't of anything down. I may have sold some at cost shares if I was risk heavy but that's about it. I would have watched and added at significant discounts (as a R/S is not a dilution; it's an opportunity to add) if that discount came.
You may not realize this but stocks move on boillinger ranges. And once recovered to top of range (possibly pre-split R/S) I would have reduced my risk and sold some of those higher "at cost" shares. No profits, but obviously my share count would have stayed in a consistent range and some of my older shares would be replaced with the newer cheaper shares. Meanwhile, you would have sat out and talked down the stock and kept waiting for the best price, and I suspect you never would bought as many shares at you once owned out of fear that it would drop more. And I would have maintained being a shareholder, holding shares that I see long term potential, but lowering my cost basis if the stock price dropped. I wouldn't of made any R/S fear selling situation worse by trying to talk shareholders into fear selling and taking losses. I wouldn't be racing you to some bottom that you think is coming. I wouldn't care if it did or it didn't come. I would simply react to the situation with an add lower/reduce higher strategy. In fact, I generally stop posting as I don't think it's right to talk anyone into buying or holding or selling. Eventually when my stocks rise I completely remove my cost and only hold free shares. And if a market opportunity presents itself then I restart with new risk capital. For instance a large percentage of my holdings are free because I reduced. I made the mistakes of selling out completely of stocks only to see the winners I picked go up another few thousand percent. Because the stock was higher than I sold I stayed out and watched. I made money, of course. But it made me change my strategy and that is why I do what I do now. I don't try to time the market. Get in and strategically add and lower cost basis. So one of us isn't "in and out" and one of us is. My strategy works for me. Yours may work for you. It is not something that I could ever stomach doing. But trust I do just fine.
Over time if I'm correct there will be good clinical news to generate new shareholder interest and HF interest of course. I obviously believe I know what I'm doing on the R/S stocks that you and I have discussed. Those that I predict will get clinical accolades, do. So far as you know TPIV has been fast tracked on results of their Phase I and they received a complete paid for large Phase II which is what I stated would happen once reviewing results.
I only like buying stock that I have no fear in holding long term and adding/reducing based on dilution and market circumstance. I'm in stocks before the big guns show up. You only like buying stock that you have no fear in trading. You have fear holding as you don't understand the science. I won't be posting on new boards so day traders won't know which stocks I have done my due diligence on and hold scientific potential.
Hopefully once and for all you will drop it. Accept we are different type of investors. I have.
Recent NWBO News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 09:10:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2024 09:24:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:01:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:01:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 09:06:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 02:42:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM